Evaluation of allergenicity of constituents of myoga using the murine local lymph node assay

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 2, 2010, Pages 463-470

  Wei, Q J ^a,b   Wei, C N ^b   Harada, Koichi ^b   Minamoto, K ^b   Okamoto, Y ^b   Otsuka, M ^b   Ueda, A ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Allergic contact dermatitis; Guinea pig maximization test (GPMT); Limonene; Limonene oxide; Local lymph node assay (LLNA); Myoga (Zingiber myoga Roscoe); Thymidine; phellandrene

Indexed keywords

BETA PHELLANDRENE; BETA PINENE; LIMONENE; LIMONENE OXIDE; PINENE; TERPENOID; UNCLASSIFIED DRUG;

ALLERGENICITY; ARTICLE; CHEMICAL COMPOSITION; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); HUMAN; LOCAL LYMPH NODE ASSAY; PLANT; PRIORITY JOURNAL; SKIN ALLERGY; TOXICITY TESTING; ZINGIBER MYOGA ROSCOE;

EID: 77955377348     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300208     Document Type: Article

References (36)

1. Makino T. Myoga. In Makino's illustrated flora in colour. Tokyo, Hokuryukan, Tokyo, 1982, p. 768. (in Japanese)
2. th Annual Meeting of Japanese Society for Contact Dermatitis. Yokohama. 2005.
3. Minamoto K, Harada K, Wei QJ, Wei CN, Ohmori S, Ueda A. Occupational allergic contact dermatitis from myoga (Zingiber Mioga rosc.) in greenhouse cultivators. Int J Immunopath Ph 2007; 20(S):31-34.
4. Lovell CR. Plants and the Skin. Black Scientific Publications. Oxford. 1993.
5. Wei QJ, Harada K, Ohmori S, Minamoto K, Wei CN, Ueda A. Toxicity study of the volatile constituents of myoga utilizing acute dermal irritation assay and the guinea-pig maximization test. J Occup Health 2006; 48:480-6.
6. Kurobayashi Y, Sakakibara H, Yanai T, Yajima I, Hayashi K. Volatile flavor components of myoga (Zingiber myoga). Agr Biol Chem 1991; 55:1655-7.
7. Mugnusson B, Kligman AM. The identification of contact allergens by animal assay. The guinea pig maximization test. J Invest Dermatol 1969; 52:268-76.
8. Harada K, Ohmori S, Wei CN, Arimatsu Y, Ueda A. Experimental study of contact dermatitis due to alstroemeria in guinea pigs. Contact Dermatitis 1998; 39:82. (Pubitemid 28410014)
9. Harada K, Ohmori S, Wei CN, Y. Arimatsu, Ueda A. Quantification of α-Methylene-γ-butyrolactone extracted from different parts of Alstroemeria Wilhelmina and evaluation of its antigenicity using the guinea-pig maximization test. Environ Health Prev Med 2002; 6:229-34. (Pubitemid 34194325)
10. OECD guideline for testing of chemicals 406. Skin Sensitisation 1992.
11. Basketter DA, Scholes W. Comparison of the local lymph node assay with the guinea-pig maximization test for the detection of a range of contact allergens. Food Chem Toxicol 1992; 30:65-9.
12. Basketter DA, Gerberrick GF, Kimber I, Loveless SE. The local lymph node assay: a viable alternative to currently accepted skin sensitization tests. Food Chem Toxicol 1996; 34:985-97. (Pubitemid 27036781)
13. Basketter DA, Blaikie L, Dearman RJ, et al. Use on the local lymph node assay for the estimation of relative contact allergenic potency. Contact Dermatitis 2000; 42:344-48. (Pubitemid 30333243)
14. Kimber I, Basketter DA. The murine local lymph node assay: A commentary on collaborative studies and new directions. Food Chem Toxicol 1992; 30:165-69.
15. Kimber I, Basketter DA, Berthold K, et al. Skin Sensitization Testing in Potency and Risk Assessment. Toxicol Sci 2001; 59:198-208. (Pubitemid 32149550)
16. Betts CJ, Dearman RJ, Heyling JR, Kimber I, Basketter DA. Skin sensitization potency of methyl metacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience. Contact Dermaitis 2006; 55:140-47. (Pubitemid 44199270)
17. Buehler EV. Occlusive patch method for skin sensitization in guinea pigs: The Buehler method. Food Chem Toxicol 1994; 32:97-101.
18. Traynor SG, Kane BJ, Betkouski MF, Hirschy LM. Facile Syntheses of optically active terpene sulfonic acids. Application to the resolution of (±)-phenylglycine. J Org Chem 1979; 44:1557-9.
19. Hirschy LM, Kane BJ, Traynor SG. Preparation of β-phellandrene. United States Patent 4,136,126. 1979.
20. Recommended Performance Standards. Murine Local Lymph Node Assay, in the URL of "http://iccvam.niehs.gov/docs/immunotoxdocs/llna-ps/LLNAPerfStds. pdf"
21. OECD Test guideline 429, 2002; OECD guideline for the testing of chemicals, Skin Sensitization: Local Lymph Node Assay. "http://iccvam. niehs.nih.gov/methods/immunotox/llnadocs/OECD429.pdf"
22. Kimber I, Dearman RJ, Basketter DA, Ryan CA, Gerbrick GF. The local lymph node assay: past, present and future. Contact Dermatitis 2002; 47:315-28. (Pubitemid 36246404)
23. Basketter DA, Lea LJ, Dickens A, Briggs D, Pate L, Dearman RJ, Kimber I. A comparison of statistical approaches to the derivation of EC3 value from local lymph node assay dose responses. J Appl Toxocol 1999; 19:261-6.
24. Warbrick EV, Dearman RJ, Lea LJ, Basketter DA, Kimber I. Local lymph node assay responses to paraphenylenediamine: intra- and inter-laboratory evaluations. J Appl Toxicol 1999; 19:255-60.
25. Gerberick GF, Ryan CA, Derman RJ, Kimber I. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals. Methods 2007; 41:54-60.
26. Lewis P, Matsumura F. Application of the local lymph node assay in dermal sensitization testing. SAP Report No. 2001 - 13A: 2001; 7-14.
27. Yamano T, Shimidzu M, Noda T. Allergenicity evaluation of p-chloro-m-cresol and p-chloro-m-xylenol by non-radioactive murine local lymph node assay and multiple-dose guinea pig maximization test. Toxicology 2003; 190:259-66.
28. Yamano T, Shimizu M, Noda T. Quantitative comparison of the results obtained by the multiple-dose guinea pig maximization test and the non-radioactive murine local lymph-node assay for various biocides. Toxicology 2005; 211:165-75.
29. Yamano T, Shimizu M. Skin sensitization potency and cross-reactivity of p-phenylenediamine and its derivatives evaluated by non-radioactive murine local lymph node assay and guinea-pig maximization test. Contact Dermatitis 2009; 60:193-8.
30. Yamashita K, Idehara K, Fukuda N, Yamaguchi G, Kawada N. Development of a modified local lymph node assay using ATP measurement as an endpoint, as an endpoint. AATEX 2005; 11:136-44.
31. Idehara K, Yamagishi G, Yamashita K, Ito M. Characterization and evaluation of a modified local lymph node assay using ATP content as a non-radio isotopic endpoint. J Pharmacolog Toxicol Meth 2008; 58:1-10.
32. Matura M, Goossens A, Bordalo O, Garcia-Bravo B, Magnusson K, Wrangsjö K, Karlberg AT. Patch testing with oxidized R-(+)-limonene and its hydroperoxide fraction. Contact Dermatitis 2003; 49:15-21.
33. Basketter DA, McFadden JF, Gerberrick F, Cockshott A, Kimber I. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH .Contact Dermatitis 2009; 60:65-9.
34. Basketter DA, Gerberick GF, Kimber I. The local lymph node assay: current position in the regulatory classification of skin sensitizing chemicals. Cutan Ocul Toxicol 2007; 26:293-301. (Pubitemid 350208869)
35. Hans-Werner V, Jürgen AH. The local lymph node assay being too sensitive? Arch Toxicol 2005; 79:721-8.
36. Kreiling R, Hollnagel HM, Hareng L, et al. Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT). Food Chem Toxicol 2008; 46:1896-904.